Abstract
To calculate the total cost per patient of prostate cancer treatment and the economic cost burden by stage, in the first year after diagnosis, for five European countries. Data from the Information Management Systems, Inc. database, survival data, expert opinion, published data and unit costs from various published official sources were used to calculate total costs per patient by stage for each country, from a payer's perspective. Diagnostic costs, first surgery, radio-, chemo- and hormonal therapy costs were included. Costs were aggregated for incident cases. The mean direct costs per patient for initial treatment were euro3698 in Germany, euro3256 in Spain, euro3682 in the UK, euro5226 in Italy and euro5851 in France. The total costs for all diagnosed patients in the first year from diagnosis were (million euro) 116.7 (UK), 244 (Germany), 385 (France), 202 (Italy) and 114.6 (Spain). The direct initial healthcare cost burden of the most common non-skin-related male cancer, prostate cancer, in France, Germany, Italy, Spain and the UK is considerable. Given the high and increasing prevalence of prostate cancer due to ageing populations in Europe, and the significant cost burden of the disease, national health policy makers shou...Continue Reading
References
Feb 15, 1995·JAMA : the Journal of the American Medical Association·A L PotoskyB S Kramer
Jul 2, 2003·Drugs & Aging·Alice K DavidGary R Hudes
Aug 2, 2003·Actas urologicas españolas·F Herranz AmoJ Turo Antona
Aug 2, 2003·Actas urologicas españolas·F Herranz AmoJ Turo Antona
Aug 16, 2003·Actas urologicas españolas·F Herranz AmoJ Turo Antona
Jul 28, 2004·Health Policy·Silvana QuagliniUNKNOWN GLADIS Study Group (Guideline Application for the Decision making in Ischemic Stroke)
Jul 16, 2005·Der Urologe. Ausg. A·K HerkommerB G Volkmer
Apr 26, 2006·The Prostate·Stijn RoemelingFritz H Schröder
Jun 8, 2006·Der Urologe. Ausg. A·T KlatteE P Allhoff
Jun 16, 2006·BJU International
Feb 9, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J FerlayP Boyle
Feb 13, 2007·International Journal of Radiation Oncology, Biology, Physics·Catherine BuronAlain Livartowski
Aug 24, 2007·The Lancet Oncology·Franco BerrinoUNKNOWN EUROCARE Working group
Aug 24, 2007·The Lancet Oncology·Arduino VerdecchiaUNKNOWN EUROCARE-4 Working Group
Oct 9, 2007·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
Dec 13, 2007·Journal of the National Cancer Institute·Rune KvåleFreddie Bray
Jan 15, 2008·BJU International·Sabina HussainRichard M Martin
Mar 7, 2008·BJU International·Georg BartschUNKNOWN Tyrol Prostate Cancer Screening Group
Apr 10, 2008·Der Urologe. Ausg. A·K KraywinkelH-W Hense
Apr 22, 2008·The Lancet Oncology·Simon M CollinJenny Donovan
May 23, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Laurent MolinierPascale Grosclaude
May 27, 2009·Prostate Cancer and Prostatic Diseases·C G RoehrbornA Benedict
Oct 13, 2009·Gynécologie, obstétrique & fertilité·P MoriceD Querleu
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Citations
Jul 3, 2013·BMC Health Services Research·Maria KellyHarry Comber
Jun 14, 2013·World Journal of Urology·Daniel W GoodS Alan McNeill
Aug 1, 2014·CMAJ Open·Alice DragomirArmen G Aprikian
Sep 6, 2013·Journal of Medical Economics·Robert G MastertonIsaac A O Odeyemi
Jul 24, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Steven R FeldmanUsha G Mallya
Jun 19, 2015·Psycho-oncology·Joachim MartiPenny Wright
Apr 2, 2013·The Journal of Urology·Yoshinobu KomaiKazunori Kihara
Dec 19, 2014·Journal of Comparative Effectiveness Research·Axel S MerseburgerDavide Meani
Sep 3, 2011·BJU International·Claus G Roehrborn, Libby K Black
Sep 25, 2015·Der Urologe. Ausg. A·V Lent, M Schultheis
Jul 4, 2015·Health Technology Assessment : HTA·Craig R RamsayThomas B Lam
Mar 25, 2014·Orvosi hetilap·Fanni RenczLászló Gulácsi
Jan 8, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·S IannazzoM Perachino
Sep 14, 2016·Asia-Pacific Journal of Clinical Oncology·Paula CroninPhilip Haywood
Mar 8, 2018·Urologia Internationalis·Axel JohnJulia Heinzelbecker
Aug 1, 2015·BMC Musculoskeletal Disorders·Hubert G NüßleinManuela Le Bars
Mar 20, 2018·Dermatology and Therapy·Jose-Manuel CarrascosaRobert Strohal
Sep 28, 2013·British Journal of Cancer·D C GreenbergV J Gnanapragasam
Sep 24, 2013·Rheumatology International·Kyriakos SouliotisProdromos Sidiropoulos
Oct 10, 2012·British Journal of Clinical Pharmacology·Joëlle M HoebertHubert G M Leufkens
Dec 20, 2013·Journal of Medical Economics·W M HartE Baskin-Bey
Mar 11, 2016·Annals of the Rheumatic Diseases·Thomas DörnerGerd R Burmester
Aug 19, 2020·Cancer Medicine·Alfred JathoNixon Niyonzima
Oct 2, 2015·European Journal of Cancer Care·L G GordonS K Chambers
Mar 18, 2017·Asia-Pacific Journal of Clinical Oncology·Merehau C MervinLouisa G Gordon
Mar 20, 2019·BMC Urology·J Smith-PalmerW Valentine
Jun 27, 2020·Frontiers in Pharmacology·Lin BaiLuwen Shi
Jun 27, 2019·BMC Health Services Research·Ho Won KangSo-Young Kim
Aug 15, 2019·BMC Public Health·Stefan ScholzWolfgang Greiner
Apr 11, 2020·BJU International·Andri Wilberg OrrasonPär Stattin
Nov 27, 2020·Journal of Palliative Care·Tony TienJames S A Green
Feb 23, 2021·Gaceta sanitaria·Oliver IbarrondoIsabel Álvarez-López
Apr 21, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Oudard, F Courbon